The Vitamin Shoppe (NYSE:VSI) was downgraded by research analysts at ValuEngine from a “buy” rating to a “hold” rating in a research note issued on Wednesday.
Several other equities research analysts have also commented on VSI. Zacks Investment Research upgraded The Vitamin Shoppe from a “strong sell” rating to a “hold” rating in a research note on Sunday, January 21st. Morgan Stanley cut their price objective on The Vitamin Shoppe from $4.00 to $3.75 and set an “equal weight” rating for the company in a research note on Wednesday, February 28th. Three investment analysts have rated the stock with a sell rating and five have given a hold rating to the company’s stock. The Vitamin Shoppe currently has an average rating of “Hold” and an average price target of $4.95.
NYSE VSI opened at $5.00 on Wednesday. The stock has a market capitalization of $121.16 million, a P/E ratio of 12.82 and a beta of 0.48. The Vitamin Shoppe has a twelve month low of $4.93 and a twelve month high of $5.10. The company has a quick ratio of 0.44, a current ratio of 1.88 and a debt-to-equity ratio of 0.47.
The Vitamin Shoppe (NYSE:VSI) last released its quarterly earnings results on Wednesday, May 9th. The specialty retailer reported $0.10 earnings per share for the quarter, hitting analysts’ consensus estimates of $0.10. The company had revenue of $295.96 million during the quarter, compared to analysts’ expectations of $293.44 million. The Vitamin Shoppe had a positive return on equity of 1.28% and a negative net margin of 22.80%. equities research analysts expect that The Vitamin Shoppe will post -0.19 EPS for the current year.
In other news, major shareholder Shah Capital Management acquired 156,142 shares of the business’s stock in a transaction on Monday, April 2nd. The stock was bought at an average cost of $4.03 per share, for a total transaction of $629,252.26. The purchase was disclosed in a legal filing with the SEC, which is available at this link. 1.07% of the stock is currently owned by insiders.
Several hedge funds have recently bought and sold shares of the company. California Public Employees Retirement System grew its position in shares of The Vitamin Shoppe by 5.0% in the first quarter. California Public Employees Retirement System now owns 282,758 shares of the specialty retailer’s stock valued at $1,230,000 after purchasing an additional 13,338 shares in the last quarter. Pinebridge Investments L.P. grew its position in shares of The Vitamin Shoppe by 28.3% in the fourth quarter. Pinebridge Investments L.P. now owns 63,860 shares of the specialty retailer’s stock valued at $281,000 after purchasing an additional 14,079 shares in the last quarter. Crossmark Global Holdings Inc. grew its position in shares of The Vitamin Shoppe by 122.8% in the fourth quarter. Crossmark Global Holdings Inc. now owns 31,320 shares of the specialty retailer’s stock valued at $138,000 after purchasing an additional 17,260 shares in the last quarter. GSA Capital Partners LLP purchased a new stake in shares of The Vitamin Shoppe in the first quarter valued at approximately $109,000. Finally, Lazard Asset Management LLC purchased a new stake in shares of The Vitamin Shoppe in the fourth quarter valued at approximately $115,000. Institutional investors and hedge funds own 97.71% of the company’s stock.
About The Vitamin Shoppe
Vitamin Shoppe, Inc, through its subsidiaries, operates as a omni-channel specialty retailer and contract manufacturer of nutritional products in the United States and internationally. It operates in two segments, Retail and Manufacturing. The company provides custom manufacturing and private labeling services for vitamin, mineral, and supplement products, as well as develops and markets own branded products.
To view ValuEngine’s full report, visit ValuEngine’s official website.
Receive News & Ratings for The Vitamin Shoppe Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for The Vitamin Shoppe and related companies with MarketBeat.com's FREE daily email newsletter.